LIGHT (TNFSF14/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 154-163

  Maña, Paula ^a   Liñares, David ^b   Silva, Diego G ^a   Fordham, Susan ^b   Scheu, Stefanie ^c   Pfeffer, Klaus ^c   Staykova, Maria ^b   Bertram, Edward M ^a  

^a Biology and Environment   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REACTIVE NITROGEN SPECIES;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BLOOD LEVEL; BONE MARROW; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DONOR; HISTOPATHOLOGY; HOST CELL; IMMUNIZATION; INFLAMMATION; LYMPHOCYTE MIGRATION; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE INJURY;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; RECOVERY OF FUNCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 84879613547     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203016     Document Type: Article

References (57)

1. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21-30. (Pubitemid 28097820)
2. Harrop, J. A., P. C. McDonnell, M. Brigham-Burke, S. D. Lyn, J. Minton, K. B. Tan, K. Dede, J. Spampanato, C. Silverman, P. Hensley, et al. 1998. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273: 27548-27556. (Pubitemid 28500476)
3. Zhai, Y., R. Guo, T. L. Hsu, G. L. Yu, J. Ni, B. S. Kwon, G. W. Jiang, J. Lu, J. Tan, M. Ugustus, et al. 1998. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102: 1142-1151. (Pubitemid 28436274)
4. Tamada, K., K. Shimozaki, A. I. Chapoval, Y. Zhai, J. Su, S. F. Chen, S. L. Hsieh, S. Nagata, J. Ni, and L. Chen. 2000. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164: 4105-4110. (Pubitemid 30215066)
5. Kwon, B. S., K. B. Tan, J. Ni, K. O. Oh, Z. H. Lee, K. K. Kim, Y. J. Kim, S. Wang, R. Gentz, G. L. Yu, et al. 1997. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272: 14272-14276. (Pubitemid 27232840)
6. Morel, Y., J. M. Schiano de Colella, J. Harrop, K. C. Deen, S. D. Holmes, T. A. Wattam, S. S. Khandekar, A. Truneh, R. W. Sweet, J. A. Gastaut, et al. 2000. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J. Immunol. 165: 4397-4404.
7. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436. (Pubitemid 26374317)
8. Gommerman, J. L., and J. L. Browning. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3: 642-655. (Pubitemid 37328667)
9. Yu, K. Y., B. Kwon, J. Ni, Y. Zhai, R. Ebner, and B. S. Kwon. 1999. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274: 13733-13736.
10. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68. (Pubitemid 40563164)
11. Ware, C. F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23: 787-819. (Pubitemid 40563185)
12. Tamada, K., J. Ni, G. Zhu, M. Fiscella, B. Teng, J. M. van Deursen, and L. Chen. 2002. Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT. J. Immunol. 168: 4832-4835. (Pubitemid 34495943)
13. Scheu, S., J. Alferink, T. Pötzel, W. Barchet, U. Kalinke, and K. Pfeffer. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 195: 1613-1624. (Pubitemid 34666074)
14. Liu, J., C. S. Schmidt, F. Zhao, A. J. Okragly, A. Glasebrook, N. Fox, E. Galbreath, Q. Zhang, H. Y. Song, S. Na, and D. D. Yang. 2003. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int. Immunol. 15: 861-870. (Pubitemid 36827075)
15. Tamada, K., K. Shimozaki, A. I. Chapoval, G. Zhu, G. Sica, D. Flies, T. Boone, H. Hsu, Y. X. Fu, S. Nagata, et al. 2000. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT costimulatory pathway. Nat. Med. 6: 283-289. (Pubitemid 30148620)
16. Ye, Q., C. C. Fraser, W. Gao, L. Wang, S. J. Busfield, C. Wang, Y. Qiu, A. J. Coyle, J. C. Gutierrez-Ramos, and W. W. Hancock. 2002. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195: 795-800. (Pubitemid 34259724)
17. Tamada, K., H. Tamura, D. Flies, Y. X. Fu, E. Celis, L. R. Pease, B. R. Blazar, and L. Chen. 2002. Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J. Clin. Invest. 109: 549-557. (Pubitemid 34171787)
18. Yu, P., and Y. X. Fu. 2008. Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev. 19: 285-294.
19. Chen, M. C., T. L. Hsu, T. Y. Luh, and S. L. Hsieh. 2000. Overexpression of bcl-2 enhances LIGHT- and interferon-gamma -mediated apoptosis in Hep3BT2 cells. J. Biol. Chem. 275: 38794-38801.
20. Wang, J., T. Chun, J. C. Lo, Q. Wu, Y. Wang, A. Foster, K. Roca, M. Chen, K. Tamada, L. Chen, et al. 2001. The critical role of LIGHT, a TNF family member, in T cell development. J. Immunol. 167: 5099-5105. (Pubitemid 33009744)
21. Zhang, M., R. Guo, Y. Zhai, and D. Yang. 2003. LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to downregulation of anti-apoptosis Bcl-2 family members. Cancer Lett. 195: 201-210. (Pubitemid 36603330)
22. Chang, Y. H., Y. Chao, S. L. Hsieh, and W. W. Lin. 2004. Mechanism of LIGHT/interferon-gamma-induced cell death in HT-29 cells. J. Cell. Biochem. 93: 1188-1202. (Pubitemid 44264132)
23. You, R. I., M. C. Chen, H. W. Wang, Y. C. Chou, C. H. Lin, and S. L. Hsieh. 2006. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3. Cancer Res. 66: 3051-3061.
24. Zhu, M., Y. Yang, Y. Wang, Z. Wang, and Y. X. Fu. 2011. LIGHT regulates inflamed draining lymph node hypertrophy. J. Immunol. 186: 7156-7163.
25. Stanley, A. C., F. de Labastida Rivera, A. Haque, M. Sheel, Y. Zhou, F. H. Amante, P. T. Bunn, L. M. Randall, K. Pfeffer, S. Scheu, et al. 2011. Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection. PLoS Pathog. 7: e1002279.
26. Xu, G., D. Liu, I. Okwor, Y. Wang, H. Korner, S. K. Kung, Y. X. Fu, and J. E. Uzonna. 2007. LIGHT is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J. Immunol. 179: 6901-6909.
27. Musicki, K., H. Briscoe, W. J. Britton, and B. M. Saunders. 2010. LIGHT contributes to early but not late control of Mycobacterium tuberculosis infection. Int. Immunol. 22: 353-358.
28. Sedgmen, B. J., W. Dawicki, J. L. Gommerman, K. Pfeffer, and T. H. Watts. 2006. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice. Int. Immunol. 18: 797-806. (Pubitemid 43779069)
29. Randall, L. M., F. H. Amante, Y. Zhou, A. C. Stanley, A. Haque, F. Rivera, K. Pfeffer, S. Scheu, G. R. Hill, K. Tamada, and C. R. Engwerda. 2008. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA. J. Immunol. 181: 7458-7462.
30. Wang, J., J. C. Lo, A. Foster, P. Yu, H. M. Chen, Y. Wang, K. Tamada, L. Chen, and Y. X. Fu. 2001. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 108: 1771-1780. (Pubitemid 34015122)
31. Wang, J., R. A. Anders, Q. Wu, D. Peng, J. H. Cho, Y. Sun, R. Karaliukas, H. S. Kang, J. R. Turner, and Y. X. Fu. 2004. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J. Clin. Invest. 113: 826-835. (Pubitemid 38544141)
32. Shaikh, R. B., S. Santee, S. W. Granger, K. Butrovich, T. Cheung, M. Kronenberg, H. Cheroutre, and C. F. Ware. 2001. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J. Immunol. 167: 6330-6337. (Pubitemid 33081564)
33. Gregory, A. P., C. A. Dendrou, K. E. Attfield, A. Haghikia, D. K. Xifara, F. Butter, G. Poschmann, G. Kaur, L. Lambert, O. A. Leach, et al. 2012. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488: 508-511.
34. Brambilla, R., J. J. Ashbaugh, R. Magliozzi, A. Dellarole, S. Karmally, D. E. Szymkowski, and J. R. Bethea. 2011. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134: 2736-2754.
35. Gommerman, J. L., K. Giza, S. Perper, I. Sizing, A. Ngam-Ek, C. Nickerson-Nutter, and J. L. Browning. 2003. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J. Clin. Invest. 112: 755-767. (Pubitemid 38057716)
36. Akassoglou, K., J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert. 1998. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153: 801-813. (Pubitemid 28419033)
37. Bachmann, R., H. P. Eugster, K. Frei, A. Fontana, and H. Lassmann. 1999. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am. J. Pathol. 154: 1417-1422. (Pubitemid 29226436)
38. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88: 1-8. (Pubitemid 28342896)
39. Racoosin, E. L., and J. A. Swanson. 1989. Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J. Exp. Med. 170: 1635-1648. (Pubitemid 19284563)
40. Glabinski, A. R., M. Krakowski, Y. Han, T. Owens, and R. M. Ransohoff. 1999. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis. J. Neurovirol. 5: 95-101. (Pubitemid 29051883)
41. Huang, D. R., J. Wang, P. Kivisakk, B. J. Rollins, and R. M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193: 713-726.
42. Staykova, M. A., L. A. Berven, W. B. Cowden, D. O. Willenborg, and M. F. Crouch. 2003. Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner. FASEB J. 17: 1337-1339.
43. Wu, M., and S. E. Tsirka. 2009. Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia 57: 1204-1215.
44. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160: 2940-2946. (Pubitemid 28136750)
45. Sahrbacher, U. C., F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, and A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28: 1332-1338.
46. Willenborg, D. O., S. A. Fordham, M. A. Staykova, I. A. Ramshaw, and W. B. Cowden. 1999. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163: 5278-5286.
47. Willenborg, D. O., M. Staykova, S. Fordham, N. O'Brien, and D. Linares. 2007. The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 191: 16-25. (Pubitemid 350060995)
48. Staykova, M. A., D. Liñares, S. A. Fordham, J. T. Paridaen, and D. O. Willenborg. 2008. The innate immune response to adjuvants dictates the adaptive immune response to autoantigens. J. Neuropathol. Exp. Neurol. 67: 543-554.
49. Bauer, J., T. Sminia, F. G. Wouterlood, and C. D. Dijkstra. 1994. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 38: 365-375. (Pubitemid 24209426)
50. Benveniste, E. N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75: 165-173. (Pubitemid 27132679)
51. Gao, Z., and S. E. Tsirka. 2011. Animal models of MS reveal multiple roles of microglia in disease pathogenesis. Neurol. Res. Int. 2011: 383087.
52. Ajami, B., J. L. Bennett, C. Krieger, K. M. McNagny, and F. M. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14: 1142-1149.
53. Pender, M. P., and M. J. Rist. 2001. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36: 137-144. (Pubitemid 33055902)
54. Bauer, J., M. Bradl, W. F. Hickley, S. Forss-Petter, H. Breitschopf, C. Linington, H. Wekerle, and H. Lassmann. 1998. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 153: 715-724. (Pubitemid 28419026)
55. Lee, Y., and P. J. McKinnon. 2009. Detection of apoptosis in the central nervous system. Methods Mol. Biol. 559: 273-282.
56. Issazadeh, S., K. Abdallah, T. Chitnis, A. Chandraker, A. D. Wells, L. A. Turka, M. H. Sayegh, and S. J. Khoury. 2000. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. J. Clin. Invest. 105: 1109-1116. (Pubitemid 30217695)
57. Anand, S., P. Wang, K. Yoshimura, I. H. Choi, A. Hilliard, Y. H. Chen, C. R. Wang, R. Schulick, A. S. Flies, D. B. Flies, et al. 2006. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J. Clin. Invest. 116: 1045-1051.